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Abstract
Background: Somatic cell nuclear transfer in cats offers a useful tool for the generation of valuable
research models. However, low birth rates after nuclear transfer hamper exploitation of the full
potential of the technology. Poor embryo development after activation of the reconstructed
oocytes seems to be responsible, at least in part, for the low efficiency. The objective of this study
was to characterize the response of cat oocytes to various stimuli in order to fine-tune existing and
possibly develop new activation methods for the generation of cat disease models by somatic cell
nuclear transfer.
Methods: First, changes in the intracellular free calcium concentration [Ca2+]i in the oocytes
induced by a number of artificial stimuli were characterized. The stimuli included electroporation,
ethanol, ionomycin, thimerosal, strontium-chloride and sodium (Na+)-free medium. The potential
of the most promising treatments (with or without subsequent incubation in the presence of
cycloheximide and cytochalasin B) to stimulate oocyte activation and support development of the
resultant parthenogenetic embryos was then evaluated. Finally, the most effective methods were
selected to activate oocytes reconstructed during nuclear transfer with fibroblasts from
mucopolysaccharidosis I- and alpha-mannosidosis-affected cats.
Results: All treatments were able to elicit a [Ca2+]i elevation in the ooplasm with various
characteristics. Pronuclear formation and development up to the blastocyst stage was most
efficiently triggered by electroporation (60.5 +/- 2.9 and 11.5 +/- 1.7%) and the combined
thimerosal/DTT treatment (67.7 +/- 1.8 and 10.6 +/- 1.9%); incubation of the stimulated oocytes
with cycloheximide and cytochalasin B had a positive effect on embryo development. When these
two methods were used to activate oocytes reconstructed during nuclear transfer, up to 84.9% of
the reconstructed oocytes cleaved. When the 2 to 4-cell embryos (a total of 220) were transferred
into 19 recipient females, 4 animals became pregnant. All of the fetuses developed from oocytes
activated by electroporation followed by cycloheximide and cytochalasin B incubation; no fetal
development was detected as a result of thimerosal/DTT activation. Although heartbeats were
detected in two of the cloned fetuses, no term development occurred.
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Conclusion: Electroporation proved to be the most effective method for the activation of cat
oocytes reconstructed by nuclear transfer. The combined thimerosal/DTT treatment followed by
cycloheximide and cytochalasin B incubation triggered development effectively to the blastocyst
stage; whether it is a viable option to stimulate term development of cloned cat embryos needs
further investigations.
Background
Ovulated mammalian oocytes are arrested at the met-
aphase stage of their second meiotic division [1]. Nor-
mally, they resume meiosis and enter the first interphase
at the time of fertilization when the fertilizing sperm acti-
vates the oocyte's developmental program by triggering
changes in its intracellular free calcium concentration
[Ca2+]i. Changes in the [Ca2+]i can also be induced artifi-
cially and as a result parthenogenetic oocyte activation
can take place. Although mammalian parthenogenetic
embryos never develop to term, a great number of inver-
tebrate and vertebrate animal species are able to repro-
duce via parthenogenesis [2].
During parthenogenetic activation, the increase in the
[Ca2+]i must be able to trigger the numerous biological
events that are associated with fertilization [3]. The proc-
ess is an integral part of several assisted reproductive tech-
nologies and has particular relevance in somatic cell
nuclear transfer [4]. Numerous oocyte activation methods
have been designed to mimic the Ca2+ signal induced by
the sperm; however, very few of them are able to generate
the oscillatory Ca2+ signal seen during mammalian fertili-
zation. Thus in most cases a single [Ca2+]i rise is induced
to stimulate development of the reconstructed oocyte [5].
Although this was shown capable of triggering oocyte acti-
vation [6], the amplitude, frequency and duration of
repetitive Ca2+  signals are believed to have profound
effects not only on the immediate events of oocyte activa-
tion but also on peri-implantation development [7].
Activation of oocytes of many domestic species including
the domestic cat has been described and used in reproduc-
tive research [8]. Cats are useful research models for a
number of reasons. They are valuable for the study of
hereditary diseases in humans since they can provide
insight into disease etiology and pathology [9-13]. Cat
models also facilitate investigation of promising treat-
ments including gene therapies, as recently shown for the
lysosomal storage diseases mucopolysaccaridosis (MPS)
and  α-mannosidosis (AMD); [14,15]. Reproductive
research on domestic cats is also important for conserving
endangered felid species [16-18]. Somatic cells isolated
from nondomestic felids can be transferred into enucle-
ated domestic cat oocytes, and it has been demonstrated
that this nuclear transfer approach has the potential of
generating live offspring if the two felid populations are
not too distantly related [19]. Despite the occasional suc-
cesses low birth rates after nuclear transfer, just like in
most other species, remain a formidable challenge. One
potential reason for the low efficiency is poor embryo
development following activation of the reconstructed
oocytes. The number of methods known to induce parthe-
nogenetic development of cat oocytes is rather low; the
published methods are limited to electroporation, etha-
nol and the ionophore A23187 [8,19]. In most cases acti-
vation techniques developed for other species have been
adopted for producing the cloned cat embryos; this may
limit embryonic development after embryo transfer. The
aims of this study were to 1) characterize [Ca2+]i changes
in cat oocytes induced by different stimuli; 2) develop
new activation methods that could be applied after
nuclear transfer to produce cleavage-stage embryos; and
3) assess the feasibility of nuclear transfer to produce
cloned cats affected with the lysosomal storage diseases
MPS or AMD.
Methods
All chemicals were purchased from Sigma-Aldrich Chem-
ical Company (St. Louis, MO, U.S.A.) unless otherwise
indicated. Experiments were conducted according to
guidelines approved by the Institutional Animal Care and
Use Committee (IACUC) at the Cincinnati Zoo & Botani-
cal Garden.
In vitro oocyte maturation
Cat ovaries were collected after routine ovariectomy.
Cumulus-oocytes complexes (COCs) were collected by
slicing in Hepes-buffered Tyrode's Lactate (TL-Hepes)
medium and matured in groups of 10 in 100-μl drops of
Feline Optimized Culture Medium (FOCM; [20]) supple-
mented with 0.1 mM cysteamine, 0.6 mM cysteine, vita-
mins (1× MEM), ITS (1×), glucose (up to a total of 6 mM),
1.0 IU/ml equine chorionic gonadotropin (eCG), 2.0 IU/
ml human chrorionic gonadotropin (hCG), 25 ng/ml epi-
dermal growth factor (EGF) and 4 mg/ml bovine serum
albumin (BSA), for 24 h. The cumulus cells were then
removed using 0.3 mg/ml hyaluronidase.
Ca2+ imaging and fluorescence measurements
Mature oocytes were loaded with the Ca2+ indicator dye
fura-2 by incubation in the presence of 2 μM fura-2 AM
(acetoxymethyl ester form) and 0.02% detergent pluronic
F-127 (Invitrogen; Carlsbad, CA, U.S.A.) for 45 min. TheReproductive Biology and Endocrinology 2009, 7:148 http://www.rbej.com/content/7/1/148
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oocytes were then rinsed and transferred to a chamber
with a glass coverslip as the bottom. They were exposed to
various treatments and changes in the [Ca2+]i  were
recorded using InCyt Im2, a dual-wavelength fluorescence
imaging system (Intracellular Imaging, Inc.; Cincinnati,
OH, U.S.A.). Fluorescence was recorded by calculating the
ratio of fura-2 fluorescence at 510 nm excited by UV light
alternatively at 340 and 380 nm. The Ca2+ concentration
was calculated by comparing the ratio of fluorescence at
340 and 380 nm against a standard curve of known Ca2+
concentration prepared with fura-2 potassium salt (Invit-
rogen). During measurements, the baseline [Ca2+]i was
detected first and then different stimuli were applied. For
each treatment, the fluorescence measurement was per-
formed for at least 10 min and then it was repeated several
times using different oocytes.
Oocyte treatments
A number of stimuli were tested for their ability to trigger
an elevation in the [Ca2+]i of the oocytes. Then, based on
the results of these measurements and on data published
in other species, a number of treatments were identified
that were deemed to have the potential to trigger parthe-
nogenetic development of the oocytes. The oocytes were
treated using the selected methods, then a portion of them
were incubated in the presence of 10 μg/ml cycloheximide
(a protein synthesis blocker) and 7.5 μg/ml cytochalasin
B (an inhibitor of actin polymerization) for 4 h prior to
culture; the rest of the oocytes were cultured without
inhibitor supplementation. In previous studies the use of
such inhibitors had a positive effect on embryo develop-
ment following oocyte activation (for review see [21]. The
oocytes were then cultured as described below and embry-
onic development induced by the different methods was
monitored. The following treatments were tested.
Electric DC pulse
Individual oocytes were transferred to a chamber with two
stainless steel electrodes where the bottom of the chamber
had been replaced with a glass coverslip. The chamber was
filled with electroporation medium (consisting of manni-
tol 0.3 M, CaCl2 0.1 mM, MgSO4 0.1 mM, HEPES 0.5 mM
and BSA 0.01 mg/ml) and placed on the stage of an
inverted microscope. After a 5-min equilibration period
the steady-state Ca2+ levels were measured, then two DC
pulses of various characteristics (1.0 kV/cm for 20 μsec;
1.2 kV/cm for 60 μsec; or 2 kV/cm for 60 μsec), 1 sec apart,
were applied to the oocytes [21] and changes in the [Ca2+]i
were monitored. To stimulate development two DC
pulses of either 1.0 kV/cm for 20 μsec or 1.2 kV/cm for 60
μsec were applied.
Ethanol
Oocytes were placed into the Ca2+ measurement chamber
containing TL-Hepes and ethanol (200 proof) was added
to the medium to obtain 7% (v/v) final ethanol concen-
tration [22]. Changes in the [Ca2+]i were recorded by the
fluorescence imaging system. In order to trigger partheno-
genetic development, oocytes were exposed to 7% (v/v)
ethanol for 5 min.
Ionomycin
Each oocyte was transferred into TL-Hepes and ionomycin
dissolved in dimethyl sulfoxide (DMSO) was added to the
medium at a final concentration of 5 or 50 μM [23]. The
same amount of DMSO without ionomycin was added to
control oocytes. For parthenogenetic development, the
oocytes were incubated in TL-Hepes in the presence of 5
or 50 μM ionomycin for 5 min.
Thimerosal
By oxidizing sulfhydryl groups on critical Ca2+ release pro-
teins thimerosal is known to elevate [Ca2+]i in oocytes
[24]. To assess whether thimerosal has the same effect in
cats, individual oocytes were transferred into TL-Hepes
and thimerosal dissolved in TL-Hepes was added at a final
concentration of 200 μM [25]. Because thimerosal oxi-
dizes sulfhydryl groups on tubulin and thus damages the
meiotic spindle, the application of a reducing agent such
as dithiothreitol (DTT) is necessary to regenerate the spin-
dle [26]. For activation, mature oocytes were treated
according to two different schemes with the sulfhydryl
modifying agents. In the first group, the oocytes were
incubated in 200 μM thimerosal for 15 min followed by a
30-min incubation in the presence of 8 mM DTT. Oocytes
in the other group were exposed to 200 μM thimerosal for
30 min followed by a 8 mM DTT treatment for 20 min.
Strontium
The oocytes were washed in Ca2+/Mg2+-free TL-Hepes
medium and transferred to the measurement chamber
containing 500 μl of the same medium. After recording
the baseline Ca2+  concentration, strontium-chloride
(SrCl2) dissolved in TL-Hepes was added at a final concen-
tration of 10 or 20 mM [27]. To induce development,
oocytes were incubated in the presence of 10 or 20 mM
SrCl2 for 4 h.
Na+-free medium
It was shown in pig oocytes that Na+-free medium can
induce repetitive Ca2+  transients via the Na+/Ca2+
exchanger [28]. Based on this finding cat oocytes were
placed individually into 10 μl TL-Hepes. Following base-
line detection, 2 ml Na+-free medium was added to the
medium that resulted in an approximately 200× dilution
of the original Na+ concentration. The Na+-free medium
consisted of choline chloride 114 mM, KCl 3.2 mM,
KH2PO4 0.4 mM, MgCl2 × 6H2O 0.5 mM, Hepes 9.2 mM,
CaCl2 × 2H2O 2 mM, PVA 0.1%, pH 7.0. For activation,Reproductive Biology and Endocrinology 2009, 7:148 http://www.rbej.com/content/7/1/148
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mature oocytes were incubated in Na+-free medium for
15, 30, 45 or 60 min.
Embryo culture and evaluation
Potential zygotes were cultured (in groups of 10) in 100
μl drops of FOCM IVC-1 medium (FOCM supplemented
with 0.4% BSA). To evaluate the formation of pronuclei
the activated oocytes were cultured for 8 h, then they were
mounted on microscope slides under posted coverslips
and placed in a fixative of ethanol: acetic acid (3:1) for 7
days. They were then stained with 1% (w/v) aceto-orcein
and evaluated for the presence or absence of pronuclei. In
order to assess development to the blastocyst stage, after 3
days of culture the groups of embryos were transferred
into 100 μl drops of FOCM IVC-2 medium (FOCM sup-
plemented with 5% fetal bovine serum) and incubated for
an additional 4 days [20]. At the end of the 7-day culture
period, the embryos were incubated in 5 μg/ml Hoechst
33342 for 15 min and the nuclei showing blue fluores-
cence were counted using an epifluorescence microscope.
Somatic cell nuclear transfer
Preparation of donor cells
The ultimate goal of these experiments was to generate
cats as models for the heritable metabolic defect MPS I or
AMD. The cell lines used as nuclear donors were generated
by skin biopsies from affected cats. The explants were cut
into small pieces and cultured in Dulbecco's Modified
Eagle's medium (DMEM, Invitrogen) supplemented with
15% fetal bovine serum and 1% penicillin/streptomycin.
Small aliquots of cells between passages 3 and 5 were fro-
zen in DMEM supplemented with 10% DMSO and stored
in liquid nitrogen until use.
Oocyte collection
Female cats were monitored daily for signs of behavioral
estrus. Blood samples were collected from anestrual
queens and the serum was assessed for progesterone to
evaluate luteal status. Non-luteal queens were adminis-
tered four intramuscular (i.m.) injections of porcine FSH
at 24 h intervals (Day 1: 9.6 IU; Day 2: 7.6 IU; Day 3: 5.7
IU; Day 4: 5.7 IU); [29]. The last FSH injection was fol-
lowed 24 h later by an i.m. injection of porcine LH (1,000
IU). Donors were anesthetized 24-27 h after the LH injec-
tion and subjected to laparoscopy and follicle aspiration.
Follicles (2-5 mm in diameter) were aspirated and the
COCs were collected in bicarbonate-buffered FOCM.
Nuclear transfer
Oocytes with an extruded polar body were enucleated in
TL-Hepes medium supplemented with 7.5 μg/ml cytoch-
alasin B. For enucleation, the first polar body and the
adjacent cytoplasm presumably containing the met-
aphase-II chromosomes were removed. (Because in previ-
ous experiments this blind enucleation led to ~85%
successfully enucleated oocytes, Hoechst staining was not
used during nuclear transfer in the present study). A
donor cell was then transferred into the perivitelline space
of each enucleated oocyte. Reconstructed oocytes were
placed in an electroporation chamber filled with Ca2+-free
electroporation medium (containing 300 mM mannitol,
0.2 mM MgSO4, 0.5 mM Hepes, 0.1% polyvinyl alcohol)
and two DC pulses (1.2 kV/cm for 60 μsec, 1 sec apart)
were applied. Following fusion, part of the reconstructed
oocytes were activated by electroporation (two pulses of
1.0 kV/cm for 20 μsec) and the rest by the combined
method of 15 min incubation with 200 μM thimerosal
followed by 30 min in 8 mM DTT. Treated oocytes were
transferred to FOCM supplemented with 10 μg/ml
cycloheximide and 7.5 μg/ml cytochalasin B for 4 h.
Potential zygotes were then washed and cultured in
FOCM/0.4% BSA until embryo transfer.
Embryo transfer
Estrual females, on Day 2 to 6 of estrus received two sub-
cutaneous injections of gonadotropin releasing hormone
(GnRH; 25 μg each, 12 h interval). The cats were anesthe-
tized 54 to 58 h after the first GnRH injection and the ova-
ries were evaluated via laparoscopy. If fresh corpora lutea
were present on the ovaries confirming the occurrence of
recent ovulations, early cleavage stage (20-38 h after
nuclear transfer) embryos (n = 8-21 per animal) were
transferred through the ostium into the lumen of the left
or right oviduct. All embryo recipient queens were sub-
jected to ultrasound examination 21-23 days after embryo
transfer. Pregnant females were reassessed with ultra-
sonography periodically to monitor fetal viability and
growth.
Statistical analysis
Frequencies of pronuclear formation, cleavage and blasto-
cyst development were compared by the chi-square test.
Total cell numbers of the blastocysts were compared by
the Student's t-test. Statistical comparisons were per-
formed using either SAS or Minitab; differences were con-
sidered significant at P < 0.05.
Results
Changes in cytosolic Ca2+ levels
Electroporation triggered an almost immediate rise in the
[Ca2+]i of cat oocytes. The application of DC pulses of
larger voltage or longer duration led to more robust
changes in cytoplasmic Ca2+ levels and increasing these
parameters above a certain threshold (e.g. raising voltage
above ~1.8 kV/cm) caused elevated intracellular Ca2+ lev-
els that did not return to baseline possibly indicating per-
manent membrane damage (data not shown). A typical
change induced by two pulses of 1 kV/cm, 20 μsec each is
shown in Figure 1A. The resting [Ca2+]i in the oocytes was
approximately 200 nM. The [Ca2+]i elevation started 3 ±Reproductive Biology and Endocrinology 2009, 7:148 http://www.rbej.com/content/7/1/148
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0.4 sec after applying the electrical shock and peaked at a
concentration of 485 ± 28 nM after which it decreased
gradually. The transient had an average duration of 73 ±
15 sec and the [Ca2+]i reached near baseline levels by the
end of the measurements (n = 15). Electroporation caused
a single [Ca2+]i rise in all oocytes tested (Table 1).
Incubation of mature cat oocytes in 7% ethanol induced
a single [Ca2+]i rise in 5 out of 12 oocytes (Figure 1B). The
elevation started at 110 ± 11 sec after adding the ethanol;
the [Ca2+]i then increased up to an average of 394 ± 87 nM
and then returned to basal levels. The mean total duration
of the Ca2+ transient was 150 ± 41 sec. Ionomycin at both
concentrations (5 and 50 μM) could elicit a rapid Ca2+
response in all (a total of 10) oocytes tested. Figure 1C
shows a [Ca2+]i change induced by 50 μM ionomycin. The
[Ca2+]i rise in these cases started within a few seconds after
adding ionomycin and peaked at a concentration of 336
± 12 nM. In all cases the [Ca2+]i elevation had an extended
duration that lasted as long as the oocyte was exposed to
the ionophore since no [Ca2+]i return to basal levels was
observed during the measurement period. The Ca2+ rise
triggered by 50 μM ionomycin started within a shorter
period of time and had higher amplitude compared to
Changes in the [Ca2+ ]i of cat oocytes induced by different stimuli Figure 1
Changes in the [Ca2+ ]i of cat oocytes induced by different stimuli. The upper part of each section shows cytoplasmic 
free Ca2+ levels as detected by a photometer; the arrows indicate the time when the stimulus was applied. In the lower part of 
each section images of [Ca2+ ]i changes in individual cat oocytes are shown; different colors indicate different intracellular free 
Ca2+ concentrations.Reproductive Biology and Endocrinology 2009, 7:148 http://www.rbej.com/content/7/1/148
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those stimulated by lower ionomycin concentration (data
not shown). DMSO alone did not elicit changes in the
[Ca2+]i (data not shown).
Incubation of mature cat oocytes with 200 μM thimerosal
induced [Ca2+]i elevation in 15 out of 18 oocytes; the sig-
nal took place as an oscillation in the intracytoplasmic
Ca2+ level in 11 oocytes. On average, the initial [Ca2+]i rise
started 356 ± 51 sec after the addition of thimerosal, with
an average peak concentration of 496 ± 75 nM and a mean
duration of 85 ± 8 sec. Subsequent rises in the [Ca2+]i were
generated at intervals of 351 ± 30 sec; the number of Ca2+
spikes induced in the oocytes was between 2 and 5. In all
oocytes the initial transient had the highest peak, each
subsequent transient tended to have a lower average
amplitude (Figure 1D). The oscillations usually lasted for
30-45 min and during this time the Ca2+  baseline
increased gradually.
Addition of SrCl2 caused a single long-lasting rise in the
[Ca2+]i in all oocytes tested (n = 30). As a result of 20 mM
SrCl2 stimulation, the baseline [Ca2+]i increased to 431 ±
52 nM within 85 ± 10 sec. The average duration of the ele-
vated [Ca2+]i was 335 ± 28 sec (Figure 1E). The lower (10
mM) SrCl2 concentration elicited a similar response in the
[Ca2+]i (data not shown).
The profile of the [Ca2+]i rise caused by Na+-free-medium
is displayed in Figure 1F. Incubation in Na+-free-medium
induced a gradual [Ca2+]i  elevation in 15 out of 28
oocytes. The rise started 135 ± 24 sec after addition of the
Na+-free-medium and peaked at a concentration of 639 ±
79 nM. The average duration of the [Ca2+]i rise induced by
the Na+-free-medium was 1,470 ± 242 sec.
Parthenogentic embryo development
The fluorescence recordings indicated that all the artificial
stimuli tested were able to generate an elevation in the
[Ca2+]i in mature cat oocytes. Next, in preliminary experi-
ments the different stimuli were evaluated for their ability
to induce parthenogenetic development and based on the
outcome of these experiments four different treatments
were finally selected and compared. The treatments
selected for further evaluation were the following: 1) elec-
troporation using two DC pulses of 1.0 kV/cm for 20 μsec
each; 2) 15 min incubation in 200 μM thimerosal fol-
lowed by a culture in 8 mM DTT for 30 min; 3) incubation
in the presence of 20 mM SrCl2 in Ca2+/Mg2+-free medium
for 4 h, and 4) a treatment in Na+-free medium for 45
min. Each treatment was applied with or without subse-
quent incubation in the presence of 10 μg/ml cyclohex-
imide and 7.5 μg/ml cytochalasin B for 4 h.
Electroportation stimulated 72 out of 119 (60.5 ± 2.9%)
oocytes to form pronuclei. Incubation of the electropo-
rated oocytes with cycloheximide and cytochalasin B
increased the percentage of oocytes having pronuclei sig-
nificantly (65 out of 81, 80.2 ± 3.1%, P < 0.05). The com-
bined thimerosal/DTT treatment induced pronuclear
formation in 84 out of 124 oocytes (67.7 ± 1.8%), this fre-
quency was significantly higher than those found after the
20 mM SrCl2 (58/114; 50.9 ± 4.0%) and Na+-free medium
(62/115; 53.9 ± 2.4%) treatments (P < 0.05). Oocytes in
these groups tended to show higher pronuclear formation
after cycloheximide and cytochalasin B incubation but the
difference was not statistically significant (Figure 2).
The cleavage frequency stimulated by electroporation was
58.2 ± 4.0% (142 out of 244 oocytes; Figure 3). The
thimerosal/DTT treatment triggered 60.6 ± 2.4% (154/
254) of the oocytes to cleave, this percentage was signifi-
cantly higher than that registered in the SrCl2-treated
group (128/262; 48.9 ± 3.6%; P < 0.05). Of the oocytes
that were activated with Na+-free medium, 54.9 ± 3.4%
(162/295) cleaved. We also found that incubation with
cycloheximide and cytochalasin B caused a significant
increase in cleavage frequency after electroporation (140/
203; 69 ± 4.2%) and SrCl2 (118/201; 58.7 ± 4.5%) treat-
ments (P < 0.05).
In the absence of incubation with the inhibitors, blasto-
cyst formation was the highest after electroporation (28/
244; 11.5 ± 1.7%) and the combined thimerosal/DTT
treatment (27/254; 10.6 ± 1.9%). These values were
Table 1: Characteristics of [Ca2+ ]i changes (mean ± SEM) induced by various artificial stimuli
Treatment No. of oocytes 
(No. of responses)
Time till response 
(sec)
Peak
[Ca2+ ]i
(nM)
Duration (sec) Oscillation Interval between 
peaks (sec)
Electroporation 15 (15) 3 ± 0.4 485 ± 28 73 ± 15 No --
7% ethanol 5 (12) 110 ± 31 394 ± 87 150 ± 41 No --
5 μM ionomycin 5 (5) 18 ± 2 277 ± 27 >800 No --
50 μM ionomycin 5 (5) 6 ± 1 336 ± 12 >800 No --
200 μM thimerosal 15 (18) 365 ± 51 496 ± 75 85 ± 8 Yes 351 ± 30
20 mM SrCl2 15 (15) 85 ± 10 431 ± 52 335 ± 28 No --
Na+-free medium 15 (28) 135 ± 24 639 ± 79 1470 ± 242 No --Reproductive Biology and Endocrinology 2009, 7:148 http://www.rbej.com/content/7/1/148
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significantly higher than those in the SrCl2 (12/262; 4.6 ±
3.6%) and Na+-free medium (16/295; 5.4 ± 3.4%) -
treated groups (P < 0.05; Figure 4). Incubation with
cycloheximide and cytochalasin B significantly improved
the frequency of blastocyst formation in oocytes that were
activated by thimerosal/DTT (44/209; 16.7 ± 2.9%), SrCl2
(24/201; 11.9 ± 2.8%) and Na+-free medium (24/245; 9.8
± 1.4%); (P < 0.05).
Somatic cell nuclear transfer
A total of 157 reconstructed oocytes were produced by
somatic cell nuclear transfer using MPS I-affected donor
cells; these oocytes were activated by electroporation fol-
lowed by incubation in cycloheximide and cytochalasin
B. Following activation 114 (72.6%) reconstructed
oocytes cleaved, the 2 to 4-cell embryos were transferred
into the oviducts of 9 recipient females. Three of these
recipients had implantations on initial palpation and
ultrasonographic exam on Day 20 to 21 post-transfer.
During early ultrasonography a total of 4 implantation
sites and 3 developing fetuses were found; one female had
only a single implantation site with no visible fetus.
Heartbeats were successfully detected in two of the
fetuses. However, by day 47 all 3 fetuses were absorbed
(Table 2). An additional 130 reconstructed oocytes were
produced by nuclear transfer using AMD-affected donor
cells; 73 of which were activated by electroporation fol-
lowed by cycloheximide and cytochalasin B incubation
while 57 were activated by thimerosal/DTT followed by
incubation with the inhibitors. In the electroporation-
Pronuclear formation in cat oocytes activated by electropo- ration (EP), thimerosal/DTT (Thi/DTT), SrCl2 and Na+-free  medium (Na+-free) with or without 4-h incubation in  cycloheximide (CHX) and cytochalasin B (Cyto B) Figure 2
Pronuclear formation in cat oocytes activated by 
electroporation (EP), thimerosal/DTT (Thi/DTT), 
SrCl2 and Na+-free medium (Na+-free) with or with-
out 4-h incubation in cycloheximide (CHX) and cyto-
chalasin B (Cyto B). The asterisk indicates a significant 
difference (P < 0.05) between frequencies of pronuclear for-
mation achieved with and without CHX/Cyto B supplemen-
tation. Different lowercase letters indicate significant 
differences between treatments without CHX/Cyto B sup-
plementation (P < 0.05); different uppercase letters indicate 
significant differences between treatments that were fol-
lowed by CHX/Cyto B incubation (P < 0.05).
Cleavage development of embryos after activation by elec- troporation (EP), thimerosal/DTT (Thi/DTT), SrCl2 and Na+- free medium (Na+-free) with or without a 4-h incubation in  cycloheximide (CHX) and cytochalasin B (Cyto B) Figure 3
Cleavage development of embryos after activation 
by electroporation (EP), thimerosal/DTT (Thi/DTT), 
SrCl2 and Na+-free medium (Na+-free) with or with-
out a 4-h incubation in cycloheximide (CHX) and 
cytochalasin B (Cyto B). The asterisks indicate significant 
differences (P < 0.05) between cleavage frequencies achieved 
with and without CHX/Cyto B supplementation. Different 
lowercase letters indicate significant differences between 
treatments without CHX/Cyto B supplementation (P < 0.05); 
different uppercase letters indicate significant differences 
between treatments where the Ca2+ signal-inducing stimulus 
was followed by CHX/Cyto B incubation (P < 0.05).
Blastocyst formation induced by parthenogenetic activation  of cat oocytes Figure 4
Blastocyst formation induced by parthenogenetic 
activation of cat oocytes. The asterisks indicate significant 
differences (P < 0.05) between frequencies of blastocyst for-
mation achieved with and without CHX/Cyto B supplemen-
tation. Different lowercase letters indicate significant 
differences between treatments without CHX/Cyto B sup-
plementation; different uppercase letters indicate significant 
differences between treatments followed by CHX/Cyto B 
incubation (P < 0.05).Reproductive Biology and Endocrinology 2009, 7:148 http://www.rbej.com/content/7/1/148
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activated group 62 oocytes (84.9%) cleaved; cleavage fre-
quency in the thimerosal/DTT-treated group was 77.2%
(44 out of 57 oocytes). The 62 cleaved embryos that were
produced by electroporation were transferred into 6 recip-
ients, of which 2 became pregnant. In the pregnant ani-
mals 4 implantation sites and 2 fetuses were detected on
day 21. The 2 to 4-cell embryos that resulted from the
thimerosal/DTT activation were transferred into 4 recipi-
ents; ultrasonography on day 21 could find neither
implantation sites nor developing fetuses in these surro-
gates. No fetuses could be detected by ultrasonography on
day 49 in any of the recipient animals.
Discussion
Following sperm-oocyte fusion, the Ca2+ signal triggered
by the fertilizing sperm is responsible for stimulating mei-
otic resumption and eventually, embryonic development.
In most cases, parthenogenetic activation methods also
induce an elevation in the [Ca2+]i to activate the oocyte's
developmental program [5]. In many species numerous
comparative studies have been carried out using different
methods of artificial activation, and the most effective
ones have been selected to activate reconstructed oocytes
after nuclear transfer. In felids no such studies have been
performed and the number of methods available for par-
thenogenetic activation of cat oocytes is rather limited. In
the present study we characterized responses of cat
oocytes to several artificial stimuli in order to find ways to
trigger [Ca2+]i changes similar to those detected during
mammalian fertilization. All the methods tested could
elicit a rise in the [Ca2+]i of cat oocytes. Electroporation is
commonly used to induce a transient elevation in the
[Ca2+]i of oocytes of various species; it has also been suc-
cessfully used to stimulate oocyte activation during cat
nuclear transfer [30]. The short, high voltage DC pulses
are known to induce a significant transmembrane Ca2+
influx by causing a destabilization of the phospholipid
bilayer. The influx is influenced by the voltage and dura-
tion of the electrical pulse as well as the ionic strength of
the electroporation medium [31]. We evaluated the effect
of DC pulses with various duration and magnetic field
characteristics; all pulses triggered changes in the [Ca2+]i.
To stimulate embryonic development we have selected a
set of parameters that induced a large [Ca2+]i elevation
without causing irreversible damage to the oocytes.
Ethanol was reported to activate oocytes of various spe-
cies. In Xenopus it was demonstrated to stimulate the pro-
duction of inositol 1,4,5-trisphosphate (IP3) which
induces the release of Ca2+ from the oocyte's intracellular
stores [32]. Its effect on cytoplasmic Ca2+ levels of cat
oocytes has never been characterized before. We found
that 7% ethanol triggered a long-lasting Ca2+ signal in cat
oocytes as well. However, the effects of ethanol on subse-
quent embryonic development have not been tested in
the present study because recently it was shown by others
that ethanol could activate ~50% of cat oocytes [8]. The
Ca2+  ionophore ionomycin has also been shown to
induce [Ca2+]i  elevations in occytes of many species.
According to the literature, the parameters of ionomycin
treatment used to activate oocytes of various species vary
significantly: concentrations ranging from 5 μM to 5 mM
[33] and treatment duration of 1 min to 40 min have also
been reported [34]. The influence of ionomycin on cat
oocytes has never been described; therefore optimizing
the concentration and incubation time is critical for suc-
cessful oocyte activation. As in other species, cat oocytes
showed a larger elevation in the intracellular free Ca2+ lev-
els after being treated with higher concentrations of iono-
mycin. Surprisingly, all the ionomycin concentrations
that we tested for the ability to induce [Ca2+]i changes
caused irreversible damages and were lethal to the
oocytes.
Thimerosal is known to oxidize sulfhydryl groups on
intracellular Ca2+ release proteins [35,36], thus causing
the release of stored Ca2+ and oscillation in the [Ca2+]i lev-
els in oocytes of a number of species [24,26,37]. Similar
to those findings, thimerosal in cat oocytes was able to
induce repetitive [Ca2+]i changes. During incubation, the
baseline [Ca2+]i  became increasingly elevated between
transients that was probably attributable to the inhibition
of Ca2+-ATPases since it was reported that thimerosal not
only induced Ca2+ release from the stores but also inhib-
ited Ca2+-ATPases and prevented the removal of excess
Ca2+ from the cytosol [38].
Table 2: Development of reconstructed cat oocytes activated by electroporation or thimerosal/DTT. 
Donor Cell 
type
Activation 
treatment
Embryos 
produced
Embryos cleaved 
and transferred 
(%)
Recipients Pregnant 
recipients
Implantation 
sites (%)
No. of fetuses 
(%)
MPS Electroporation 157 114 (72.6) 9 2* 4 (3.5) 3 (2.6)
AMD Electroporation 73 62 (84.9) 6 2 4 (6.5) 2 (3.2)
AMD Thimerosal/DTT 57 44 (77.2) 4 0 0 (0) 0 (0)
Stimulated oocytes in both cases were subsequently incubated in cycloheximide and cytochalasin B for 4 h.
*A third female had a single implantation site but with no observable fetusReproductive Biology and Endocrinology 2009, 7:148 http://www.rbej.com/content/7/1/148
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Incubation in the presence of Sr2+ induces activation in
mouse oocytes [39] but the mechanism of its action has
not been completely elucidated. Because in certain cell
types Sr2+ is handled similar to Ca2+ it was proposed that
Sr2+  activates oocytes by displacing bound Ca2+  [40].
Recent studies showed that by using a low molecular
weight heparin to antagonize the function of IP3 receptors
or treating oocytes with the phospholipase C inhibitor
U73122, the Sr2+-induced [Ca2+]i  increases in mouse
oocytes were blocked and this inhibitory effect could be
rescued by microinjection of IP3. These results indicated
that Sr2+ triggered the release of stored Ca2+ through the
IP3 receptors [41]. Although in mice Sr2+ treatment leads
to an oscillation in the oocyte [Ca2+]i, we found that in cat
oocytes Sr2+ triggered a single, long-lasting Ca2+ elevation.
The effects of Na+-free medium have been described in the
pig where it was reported to induce oscillatory changes in
the [Ca2+]i; [28]. In approximately 50% of the cases, Na+-
free medium also stimulated a [Ca2+]i elevation in cat
oocytes with a high amplitude and long duration. The
effect of the Na+-free medium is probably mediated by the
Na+/Ca2+ exchanger expressed in the plasma membrane of
cat oocytes. The Na+/Ca2+ exchanger uses the energy of a
Na+ gradient to move Ca2+ [42]. However, in case of low
extracellular Na+ levels the exchanger can operate in a
reverse mode, pumping Ca2+ into the cell. This feature of
the exchanger makes Na+-free medium a potential candi-
date for stimulating oocyte activation. The exchanger was
found to be present in hamster [43], mouse [44,45] and
porcine [28] oocytes. Because Na+-free medium triggered
an elevation in the [Ca2+]i we decided to investigate its
ability to stimulate parthenogenetic development in cat
oocytes.
Based on the results of the fluorescence measurements,
four different methods have been selected to activate cat
oocytes. As a result of the treatments, pronuclear forma-
tion in the oocytes ranged between 50.9% and 67.7%. The
combined thimerosal/DTT treatment followed by
cycloheximide and cytochalasin B incubation led to blas-
tocyst formation in 21.1% of the cases. This frequency is
similar to that received after electroporation, the method
most widely used for oocyte activation. Although thime-
rosal is able to induce Ca2+ oscillation in oocytes, it also
oxidizes sulfhydryl groups on tubulin that prevents fur-
ther development [46]. In order to eliminate its negative
effects, the thimerosal treatment must be followed by an
incubation in the presence of the sulfhydryl-reducing
compound DTT [26]. The high percentage of blastocyst
formation achieved in the present study indicates for the
first time that the thimerosal/DTT activation is an effective
way to stimulate parthenogenetic embryo development in
cats.
Even though blastocyst formations induced by SrCl2 or
Na+-free medium were somewhat low, this is the first
report to demonstrate that these stimuli can trigger cat
oocyte activation and subsequent blastocyst develop-
ment. Although Na+-free medium has previously been
reported to induce [Ca2+]i increases in porcine oocytes, no
subsequent embryo development has been observed [28].
Here we found that Na+-free medium could induce cleav-
age of cat oocytes with a frequency similar to that triggered
by electroporation or the combined thimerosal/DTT treat-
ment, although the subsequent blastocyst formation was
lower compared to the other treatments. It is possible that
the amplitude of the Ca2+ signal induced by the Na+-free
medium is insufficient to induce complete egg activation.
This is in accordance with the finding that in rabbit the
amplitude of the Ca2+ transient did not appear to affect
early cleavage but it influenced the developmental compe-
tence of the produced embryo [7]. Another reason for the
low blastocyst formation may be that sustained high lev-
els of [Ca2+]i induced via the Na+/Ca2+ exchanger caused
cellular damage that negatively influenced developmental
competence. Although optimization of the Na+-free treat-
ment was attempted in this study, the improvement in
embryonic development was not significant. Additional
studies focusing on the fine-tuning of this method may be
helpful to develop a method that utilizes the Ca2+ signal
generated via the Na+/Ca2+ exchanger for oocyte activa-
tion.
The results obtained also showed that incubation of cat
oocytes in cycloheximide and cytochalasin B after an
induced Ca2+ signal increased the frequency of pronuclear
formation, cleavage and blastocyst formation. Mature
mammalian oocytes arrested at the second metaphase
stage synthesize cyclin B continuously in order to main-
tain activity of the M-phase Promoting Factor (MPF). Dur-
ing activation, MPF activity has to drop in order to allow
release from the metaphase II arrest [47]. Cycloheximide
is a protein synthesis inhibitor that blocks the production
of cyclin B and in turn decreases MPF activity. Cytochala-
sin B on the other hand is an inhibitor of actin polymeri-
zation frequently used to block the extrusion of second
polar body. In the presence of cytochalasin B, segregation
of the chromosomes occurs after parthenogenetic oocyte
activation but cytokinesis does not take place which
results in the formation of diploid zygotes with two pro-
nuclei [22,48]. In our experiments, incubation of cat
oocytes with cycloheximide and cytochalasin B had the
tendency to improve pronuclear formation, cleavage fre-
quency and blastocyst development after every single Ca2+
elevation-inducing stimulus tested and the improvement
was significant in several cases. Although the incubation
did not increase the total cell number of the developing
blastocysts, the results indicate that these inhibitors areReproductive Biology and Endocrinology 2009, 7:148 http://www.rbej.com/content/7/1/148
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beneficial to increase the efficiency of oocyte activation in
the cat.
The objective of the oocyte activation experiments was to
develop potential methods to be used during nuclear
transfer for the generation of useful disease models. In the
domestic cat, somatic cell nuclear transfer not only pro-
vides the opportunity to generate genetically identical ani-
mals for research purposes, it also has the potential to
facilitate preservation of rare and valuable felid popula-
tions, including cat research models and possibly endan-
gered felid species [30]. In addition, domestic cats are
useful research models for the study of more than 200
human hereditary diseases [49]. Maintenance of cat dis-
ease models can be challenging however, because the dis-
ease state may interfere with normal breeding, gestation
and/or parturition. The application of nuclear transfer
technology offers an innovative approach. Cloning would
eliminate the need to collect gametes from affected ani-
mals for in vitro fertilization, it would obviate the require-
ment to maintain populations of carrier (heterozygous)
cats, and for cat models that do not survive to sexual
maturity cloning would provide a direct method for their
continued propagation. Based on the frequency of blasto-
cyst formation they induced, two methods were selected
to activate reconstructed cat oocytes after nuclear transfer.
These methods included electroporation and the
combined thimerosal/DTT treatment, each followed by
incubation in the presence of cycloheximide and cytocha-
lasin B.
For nuclear transfer, fibroblast cells from two animals
affected by different metabolic defects were collected and
used as nuclear donors. The defects included AMD and
MPS I, two lysosomal storage diseases that have been
extensively characterized in cats. They are homologous to
human inborn errors, involve single gene mutations and
inherited as autosomal recessive traits [49,50]. These
models have been instrumental in demonstrating the
value of bone marrow transplantation in alleviating these
diseases and, most recently, the potential of gene therapy
using an adeno-associated viral vector for treating AMD-
affected cats [14,15]. Cats affected with MPS I are difficult
to breed naturally due to musculoskeletal abnormalities
whereas AMD-affected cats typically die before reaching
puberty.
Transfer of cloned embryos in which development was
stimulated with electroporation followed by cyclohex-
imide and cytochalasin B incubation resulted in 5 females
having distinct implantation sites and 4 females with
established pregnancies (i.e., presence of at least one
fetus). Despite a total of 8 implantation sites, 5 fetuses
and detectable heartbeats in two fetuses, no term develop-
ment occurred; all fetuses were eventually reabsorbed by
day 49 of pregnancy. Our previous research has demon-
strated the developmental competence to term of MPS-
affected and MPS-carrier IVF embryos following transfer
into our primary recipient type [51]. Pregnancy loss in the
current study may be attributable to deficient reprogram-
ming of the donor nucleus in the enucleated oocyte or
aberrant chromosome numbers as a result of incomplete
enucleation. Furthermore, no pregnancies were detected
following thimerosal/DTT-induced oocyte activation
which was somewhat unexpected. Nevertheless, the
thimerosal/DTT treatment stimulated cleavage divisions
at a frequency comparable to that achieved by electropo-
ration. This, in light of a recent report showing that the
thimerosal/DTT activation supported term development
of cloned transgenic piglets [52] implies that successful
activation can be achieved by modification of sulfhydryl
groups on key Ca2+ releasing proteins in cat oocytes.
Conclusion
This study described a number of novel methods to
induce Ca2+ release in cat oocytes for the stimulation of
embryo development. In addition, the results support pre-
vious findings that electroporation is an effective way for
the activation of oocytes reconstructed by nuclear transfer.
Based on in vitro data, the combined thimerosal/DTT acti-
vation may also be suitable for cat oocyte activation but
this needs further verification from additional studies.
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